HEALTH● LOWSep 14 · Sep 14, 2026, 3:58 PM
Definium rises as LSD pill achieves primary goal in late-stage trial for anxiety
Seeking Alpha Tech · global
Definium's stock rose following the successful achievement of primary goals in a late-stage clinical trial for an LSD pill designed to treat anxiety. This indicates progress in psychedelic-assisted therapy research.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH22m agoProbiotic cuts risk of respiratory infections in formula-fed babiesNew ScientistHEALTH52m agoCleft lip and palate and other craniofacial surgery for kids isn’t cosmetic, it’s lifesavingThe HillHEALTH1h agoHong Kong’s Hospital Authority appeals for liver donor for boy, 13South China Morning PostHEALTH1h agoInside Bunia’s fight to protect families from DRC’s deadliest Ebola outbreakRFI [en]